GARDNER, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense ...
GARDNER, Mass., Dec. 4, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense / ...
Role of circulating tumor DNA (ctDNA) in locally advanced (LA) and metastatic urothelial cancer (mUC). Clinical features of patients with malignant lesions detected by BLC only (A) and those with risk ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
NEW ORLEANS -- Using a tool to classify patients' infection risk and providing education and systems-level changes in the urology department safely reduced prophylactic antibiotic use around ...
Accurate documentation of lesions during transurethral resection of bladder tumors (TURBT) is essential for precise diagnosis, treatment planning, and follow-up care. However, optimizing schematic ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
Host Rick Bangs’s special guest is Yair Lotan, M.D., a Professor of Urology, Chief of Urologic Oncology, at UT Southwestern Medical Center. When do urologists use a cystoscopy and why? What are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results